ContextVision AB (CONTX) - Net Assets
Based on the latest financial reports, ContextVision AB (CONTX) has net assets worth Nkr91.22 Million NOK (≈ $9.60 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr126.34 Million ≈ $13.29 Million USD) and total liabilities (Nkr35.12 Million ≈ $3.70 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is ContextVision AB's equity to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr91.22 Million |
| % of Total Assets | 72.2% |
| Annual Growth Rate | 3.28% |
| 5-Year Change | 143.79% |
| 10-Year Change | 50.03% |
| Growth Volatility | 23.18 |
ContextVision AB - Net Assets Trend (2002–2025)
This chart illustrates how ContextVision AB's net assets have evolved over time, based on quarterly financial data. See how many days can ContextVision AB fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for ContextVision AB (2002–2025)
The table below shows the annual net assets of ContextVision AB from 2002 to 2025. For live valuation and market cap data, see CONTX market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr92.16 Million ≈ $9.70 Million |
-2.22% |
| 2024-12-31 | Nkr94.26 Million ≈ $9.92 Million |
+21.11% |
| 2023-12-31 | Nkr77.83 Million ≈ $8.19 Million |
+16.98% |
| 2022-12-31 | Nkr66.53 Million ≈ $7.00 Million |
+75.99% |
| 2021-12-31 | Nkr37.80 Million ≈ $3.98 Million |
-52.62% |
| 2020-12-31 | Nkr79.78 Million ≈ $8.40 Million |
+20.63% |
| 2019-12-31 | Nkr66.14 Million ≈ $6.96 Million |
+12.93% |
| 2018-12-31 | Nkr58.56 Million ≈ $6.16 Million |
-1.32% |
| 2017-12-31 | Nkr59.35 Million ≈ $6.24 Million |
-3.39% |
| 2016-12-31 | Nkr61.43 Million ≈ $6.46 Million |
+7.70% |
| 2015-12-31 | Nkr57.04 Million ≈ $6.00 Million |
+12.38% |
| 2014-12-31 | Nkr50.75 Million ≈ $5.34 Million |
+11.47% |
| 2013-12-31 | Nkr45.53 Million ≈ $4.79 Million |
+10.93% |
| 2012-12-31 | Nkr41.05 Million ≈ $4.32 Million |
+1.53% |
| 2011-12-31 | Nkr40.42 Million ≈ $4.25 Million |
+10.17% |
| 2010-12-31 | Nkr36.69 Million ≈ $3.86 Million |
-9.80% |
| 2009-12-31 | Nkr40.68 Million ≈ $4.28 Million |
-17.88% |
| 2008-12-31 | Nkr49.53 Million ≈ $5.21 Million |
-8.87% |
| 2007-12-31 | Nkr54.36 Million ≈ $5.72 Million |
+5.21% |
| 2006-12-31 | Nkr51.67 Million ≈ $5.44 Million |
+17.93% |
| 2005-12-31 | Nkr43.81 Million ≈ $4.61 Million |
+36.67% |
| 2004-12-31 | Nkr32.06 Million ≈ $3.37 Million |
-22.26% |
| 2003-12-31 | Nkr41.24 Million ≈ $4.34 Million |
-5.94% |
| 2002-12-31 | Nkr43.84 Million ≈ $4.61 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ContextVision AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2247.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Nkr86.85 Million | 94.24% |
| Common Stock | Nkr2.08 Million | 2.26% |
| Other Components | Nkr3.22 Million | 3.50% |
| Total Equity | Nkr92.16 Million | 100.00% |
ContextVision AB Competitors by Market Cap
The table below lists competitors of ContextVision AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Microlink Solutions Bhd
KLSE:0126
|
$28.27 Million |
|
Inalways
TWO:5398
|
$28.29 Million |
|
HeraMED Limited
F:1I4
|
$28.30 Million |
|
Galva Technologies Tbk PT
JK:GLVA
|
$28.30 Million |
|
RSL Electronics Ltd
TA:RSEL
|
$28.22 Million |
|
SoftOx Solutions AS
OL:SOFTX
|
$28.22 Million |
|
G11 Resources Ltd
AU:G11
|
$28.21 Million |
|
Tikun Olam Cannbit Pharmaceuticals Ltd
TA:TKUN
|
$28.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ContextVision AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 94,257,000 to 92,160,000, a change of -2,097,000 (-2.2%).
- Net income of 787,000 contributed positively to equity growth.
- Share repurchases of 2,812,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr787.00K | +0.85% |
| Share Repurchases | Nkr2.81 Million | -3.05% |
| Other Changes | Nkr-72.00K | -0.08% |
| Total Change | Nkr- | -2.22% |
Book Value vs Market Value Analysis
This analysis compares ContextVision AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.02x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 7.10x to 3.02x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | Nkr0.51 | Nkr3.60 | x |
| 2003-12-31 | Nkr0.50 | Nkr3.60 | x |
| 2004-12-31 | Nkr0.38 | Nkr3.60 | x |
| 2005-12-31 | Nkr0.53 | Nkr3.60 | x |
| 2006-12-31 | Nkr0.62 | Nkr3.60 | x |
| 2007-12-31 | Nkr0.65 | Nkr3.60 | x |
| 2008-12-31 | Nkr0.61 | Nkr3.60 | x |
| 2009-12-31 | Nkr0.52 | Nkr3.60 | x |
| 2010-12-31 | Nkr0.47 | Nkr3.60 | x |
| 2011-12-31 | Nkr0.52 | Nkr3.60 | x |
| 2012-12-31 | Nkr0.53 | Nkr3.60 | x |
| 2013-12-31 | Nkr0.59 | Nkr3.60 | x |
| 2014-12-31 | Nkr0.66 | Nkr3.60 | x |
| 2015-12-31 | Nkr0.74 | Nkr3.60 | x |
| 2016-12-31 | Nkr0.79 | Nkr3.60 | x |
| 2017-12-31 | Nkr0.77 | Nkr3.60 | x |
| 2018-12-31 | Nkr0.76 | Nkr3.60 | x |
| 2019-12-31 | Nkr0.85 | Nkr3.60 | x |
| 2020-12-31 | Nkr1.03 | Nkr3.60 | x |
| 2021-12-31 | Nkr0.49 | Nkr3.60 | x |
| 2022-12-31 | Nkr0.86 | Nkr3.60 | x |
| 2023-12-31 | Nkr1.01 | Nkr3.60 | x |
| 2024-12-31 | Nkr1.22 | Nkr3.60 | x |
| 2025-12-31 | Nkr1.19 | Nkr3.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ContextVision AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.71%
- • Asset Turnover: 0.88x
- • Equity Multiplier: 1.35x
- Recent ROE (0.85%) is below the historical average (9.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 8.44% | 10.55% | 0.68x | 1.17x | Nkr-684.00K |
| 2003 | -6.07% | -9.32% | 0.56x | 1.17x | Nkr-6.63 Million |
| 2004 | -28.52% | -37.10% | 0.67x | 1.14x | Nkr-12.35 Million |
| 2005 | 26.64% | 20.82% | 0.96x | 1.33x | Nkr7.29 Million |
| 2006 | 11.93% | 11.87% | 0.80x | 1.26x | Nkr998.20K |
| 2007 | 37.37% | 29.42% | 0.98x | 1.30x | Nkr14.88 Million |
| 2008 | 40.77% | 28.41% | 1.06x | 1.35x | Nkr15.24 Million |
| 2009 | -20.29% | -15.08% | 1.10x | 1.22x | Nkr-12.32 Million |
| 2010 | -8.99% | -6.17% | 1.18x | 1.23x | Nkr-6.97 Million |
| 2011 | 8.85% | 6.13% | 1.20x | 1.20x | Nkr-464.50K |
| 2012 | 1.51% | 0.92% | 1.23x | 1.33x | Nkr-3.48 Million |
| 2013 | 10.72% | 7.96% | 1.07x | 1.26x | Nkr327.00K |
| 2014 | 10.68% | 8.42% | 1.02x | 1.25x | Nkr345.70K |
| 2015 | 9.36% | 7.39% | 1.00x | 1.27x | Nkr-365.60K |
| 2016 | 6.92% | 5.19% | 1.03x | 1.29x | Nkr-1.89 Million |
| 2017 | -2.87% | -2.12% | 1.02x | 1.33x | Nkr-7.64 Million |
| 2018 | -2.01% | -1.30% | 1.18x | 1.31x | Nkr-7.04 Million |
| 2019 | 11.19% | 7.76% | 1.03x | 1.40x | Nkr784.40K |
| 2020 | 15.14% | 12.75% | 0.89x | 1.33x | Nkr4.10 Million |
| 2021 | -20.24% | -7.80% | 0.89x | 2.93x | Nkr-11.43 Million |
| 2022 | 43.28% | 24.44% | 1.21x | 1.47x | Nkr22.14 Million |
| 2023 | 42.05% | 24.76% | 1.28x | 1.33x | Nkr24.95 Million |
| 2024 | 26.18% | 18.89% | 1.00x | 1.38x | Nkr15.25 Million |
| 2025 | 0.85% | 0.71% | 0.88x | 1.35x | Nkr-8.43 Million |
Industry Comparison
This section compares ContextVision AB's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $9,257,590
- Average return on equity (ROE) among peers: -282.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ContextVision AB (CONTX) | Nkr91.22 Million | 8.44% | 0.39x | $28.23 Million |
| CodeLab Capital A/S (CODE) | $17.91 Million | -842.64% | 0.15x | $4.44 Million |
| Induct AS (INDCT) | $4.91 Million | -43.99% | 3.47x | $5.24 Million |
| Nordhealth AS (NORDH) | $4.95 Million | 38.92% | 1.60x | $102.35 Million |
About ContextVision AB
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image … Read more